1. Government of Japan. Pharmaceutical Affairs Law [in Japanese]. Law No. 145 of 1960. Final rev ed. Tokyo, Japan; June 21, 2006.
2. Kawakami K, Yamane H. Clinical research in Japan: ways to alleviate unnecessary regulatory burdens. RECIIS Elect J Commun Inf Innov Health. 2007;1:57–61.
3. Imamura CK, Takebe N, Nakamura S, Saya H, Ueno NT. Experimental therapies: investigator-initiated cancer trials with INDs for approval in Japan. Nat Rev Clin Oncol. 2010;7:127–128.
4. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonized Tripartite Guideline: Guideline for Good Clinical Practice E6(R1). 1996.
5. Ministry of Health Labour and Welfare. Ethical Guidelines for Clinical Researches. Tokyo, Japan; 2008.